Kanagawa, Japan

Jinichi Yonemori


 

Average Co-Inventor Count = 11.8

ph-index = 3

Forward Citations = 25(Granted Patents)


Location History:

  • Osaka, JP (2011)
  • Fujisawa, JP (2018 - 2024)
  • Kanagawa, JP (2018 - 2024)

Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):

Title: The Innovative Journey of Jinichi Yonemori

Introduction: Jinichi Yonemori is a notable inventor based in Kanagawa, Japan. With a remarkable portfolio, he holds 12 patents in the field of heterocyclic compounds, contributing significantly to the realm of medicinal chemistry. His groundbreaking inventions focus on therapeutic solutions for various central nervous system diseases.

Latest Patents: Among his latest innovations, Yonemori has introduced a heterocyclic compound exhibiting HDAC inhibitory action. This compound holds promise for treating central nervous system diseases, particularly neurodegenerative conditions. Additionally, he has developed another heterocyclic compound anticipated to serve as a prophylactic or therapeutic agent for depression, bipolar disorder, migraines, and other related ailments. Both inventions involve compounds represented by specific formulas as detailed in their respective patent descriptions.

Career Highlights: Currently, Jinichi Yonemori is affiliated with Takeda Pharmaceutical Company Limited, where he continues his research and development endeavors. His work exemplifies the fusion of scientific rigor and innovation, significantly advancing the field of therapeutics. His dedication to improving patient outcomes through innovative solutions is commendable.

Collaborations: Collaborating with esteemed colleagues, including Masami Yamada and Makoto Kamata, Yonemori fosters a dynamic environment for creativity and scientific exploration. These partnerships enhance the development of new compounds and therapeutic strategies, reinforcing the importance of teamwork in advancing healthcare solutions.

Conclusion: Jinichi Yonemori stands out as a leading inventor in the pharmaceutical domain, with a solid foundation of patents that embody his commitment to innovation. His contributions not only bolster Takeda Pharmaceutical Company Limited but also positively impact the treatment landscape for patients suffering from various central nervous system disorders. As he continues to explore the boundaries of medicinal chemistry, the academic and healthcare communities eagerly anticipate his future breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…